Suppr超能文献

丝氨酸蛋白酶抑制剂对凝血酶的抑制作用。

Thrombin inhibition by the serpins.

机构信息

Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, UK.

出版信息

J Thromb Haemost. 2013 Jun;11 Suppl 1:254-64. doi: 10.1111/jth.12252.

Abstract

Thrombin is the central protease in the blood coagulation network. It has multiple substrates and cofactors, and it appears that four serpins are responsible for inhibiting the thrombin produced in haemostasis and thrombosis. Structural studies conducted over the last 10 years have resolved how thrombin recognises these serpins with the aid of cofactors. Although antithrombin (AT), protein C inhibitor (PCI), heparin cofactor II (HCII) and protease nexin-1 (PN1) all share a common fold and mechanism of protease inhibition, they have evolved radically different mechanisms for cofactor-assisted thrombin recognition. This is likely to be due to the varied environments in which thrombin is found. In this review, I discuss the unusual structural features of thrombin that are involved in substrate and cofactor recognition, the serpin mechanism of protease inhibition and the fate of thrombin in the complex, and how the four thrombin-specific serpins exploit the special features of thrombin to accelerate complex formation.

摘要

凝血酶是血液凝固网络中的中心蛋白酶。它有多个底物和辅因子,似乎有四种丝氨酸蛋白酶抑制剂(serpins)负责抑制止血和血栓形成中产生的凝血酶。过去 10 年的结构研究已经解决了凝血酶如何在辅因子的帮助下识别这些丝氨酸蛋白酶抑制剂的问题。尽管抗凝血酶 (AT)、蛋白 C 抑制剂 (PCI)、肝素辅因子 II (HCII) 和蛋白酶纳新素-1 (PN1) 都具有共同的折叠和蛋白酶抑制机制,但它们为辅因子辅助的凝血酶识别进化出了截然不同的机制。这可能是由于凝血酶所处的环境不同。在这篇综述中,我讨论了参与底物和辅因子识别的凝血酶的不寻常结构特征、丝氨酸蛋白酶抑制剂的机制以及复合物中凝血酶的命运,以及四种凝血酶特异性丝氨酸蛋白酶抑制剂如何利用凝血酶的特殊性质来加速复合物的形成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验